These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21984246)

  • 1. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
    Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
    Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.
    Parlane NA; Grage K; Mifune J; Basaraba RJ; Wedlock DN; Rehm BH; Buddle BM
    Clin Vaccine Immunol; 2012 Jan; 19(1):37-44. PubMed ID: 22072720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.
    Martínez-Donato G; Piniella B; Aguilar D; Olivera S; Pérez A; Castañedo Y; Alvarez-Lajonchere L; Dueñas-Carrera S; Lee JW; Burr N; Gonzalez-Miro M; Rehm BH
    Clin Vaccine Immunol; 2016 Apr; 23(4):370-8. PubMed ID: 26888185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review.
    Parlane NA; Rehm BH; Wedlock DN; Buddle BM
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):8-13. PubMed ID: 23707076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.
    Xu P; Wang Y; Tao L; Wu X; Wu W
    Biotechnol Lett; 2019 Jul; 41(6-7):867-872. PubMed ID: 31119429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
    Zhang Q; Zhong J; Huan L
    Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity.
    Berlec A; Malovrh T; Zadravec P; Steyer A; Ravnikar M; Sabotič J; Poljšak-Prijatelj M; Štrukelj B
    Appl Microbiol Biotechnol; 2013 May; 97(10):4333-42. PubMed ID: 23371298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines.
    Rubio Reyes P; Parlane NA; Wedlock DN; Rehm BH
    Int J Med Microbiol; 2016 Dec; 306(8):624-632. PubMed ID: 27756533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
    Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
    Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.
    Bermúdez-Humarán LG; Langella P; Cortes-Perez NG; Gruss A; Tamez-Guerra RS; Oliveira SC; Saucedo-Cardenas O; Montes de Oca-Luna R; Le Loir Y
    Infect Immun; 2003 Apr; 71(4):1887-96. PubMed ID: 12654805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
    Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
    Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination.
    Pei H; Liu J; Cheng Y; Sun C; Wang C; Lu Y; Ding J; Zhou J; Xiang H
    Appl Microbiol Biotechnol; 2005 Aug; 68(2):220-7. PubMed ID: 15660214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice.
    Sun N; Zhang R; Duan G; Peng X; Wang C; Chen S; Fan Q
    Biotechnol Lett; 2019 Dec; 41(12):1415-1421. PubMed ID: 31620902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of functionalized biopolyester granules by recombinant Lactococcus lactis.
    Mifune J; Grage K; Rehm BH
    Appl Environ Microbiol; 2009 Jul; 75(14):4668-75. PubMed ID: 19465535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.
    Parlane NA; Wedlock DN; Buddle BM; Rehm BH
    Appl Environ Microbiol; 2009 Dec; 75(24):7739-44. PubMed ID: 19837843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
    Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
    Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of recombinant Lactococcus expressing thymosin and interferon fusion protein and its application as an immune adjuvant.
    Liu Z; Zhang S; Hu H; Wang H; Qiu Y; Dong M; Wang M; Cui Z; Cui H; Wang Y; He G
    Microb Cell Fact; 2024 Feb; 23(1):40. PubMed ID: 38321474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.